Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 42.00
Bid: 40.00
Ask: 44.00
Change: 0.00 (0.00%)
Spread: 4.00 (10.00%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 40.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

European plan to boost marine & coastal economies

30 Apr 2019 07:00

RNS Number : 4480X
Frontier IP Group plc
30 April 2019
 

30 April 2019

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Frontier IP part of pan-European project to boost marine and coastal economies by maximising research impact

 

 

Frontier IP, a specialist in commercialising intellectual property, today announces it has been selected as a partner in a major project to maximise the value of academic research to Europe's marine and coastal economies - the European Blue Economy.

 

The project, called Emporia4KT, aims to build bridges between academia, business and government to develop ways to transfer academic knowledge and innovation to boost activities such as fishing, shipbuilding, tourism and ocean energy.

 

It brings together 14 partners from Portugal, Ireland, France, Spain and the United Kingdom, and is being coordinated by one of Frontier IP's partner universities in Portugal, NOVA University Lisbon, NOVA School of Science and Technology ("FCT NOVA"). Frontier IP's critical role will be to develop tools to help partners assess risks, judge cost effectiveness, and understand the most appropriate routes for commercialising their IP.

 

Emporia4KT is backed by approximately €2.2 million funding from the European Union's INTERREG Atlantic Area European Regional Development Fund. Frontier IP will receive fees for its involvement in the project.

 

Frontier IP chief executive officer Neil Crabb said: "We are delighted to be involved in this high-profile project, which gives us the opportunity to support institutions from across Europe as they seek to help the European Blue Economy benefit from the work they do."

 

FCT NOVA Prof. António Grilo and Emporia4KT coordinator said: "Our motivation is to create social-economic impact from academic research activities within the blue economy sectors, while also transforming the relationship between the triple helix actors for innovation - academia, business and government."

 

 

The full statement from INTERREG Atlantic Area funding programme is below and can be downloaded here:

http://www.rns-pdf.londonstockexchange.com/rns/4480X_1-2019-4-29.pdf

 

New project launched to boost European marine and coastal economies by maximising research impact - EMPORIA4KT

 

Press release: April 2019

 

An exciting new project from the European Union's (EU) INTERREG Atlantic Area funding programme will focus on assisting academics to transfer knowledge from their research in order to create value in the European Blue Economy. The Blue Economy represents all economic activities related to oceans, seas and coastal areas and includes industries such as fishing, shipbuilding, tourism and ocean energy. This growing sector is hugely important to Europe, and currently provides jobs for nearly 3.5 million people.

 

The project, EMPORIA4KT, will work to forge links between academia, business and government through tailored activities such as workshops targeting the needs of all key stakeholders.

 

António Grilo, EMPORIA4KT coordinator, states "Our motivation is to create social-economic impact from academic research activities within the blue economy sectors, while also transforming the relationship between the triple helix actors for innovation - academia, business and government."

 

The project will train researchers to use the project's knowledge transfer methodology to identify specific potential users of their research outputs and connect directly to them in a productive and effective way. It is expected that these connections will strengthen innovation and competitiveness in the Atlantic Area Blue Economy, with high potential for increasing growth and generating jobs. This will in turn provide a greater return on research investment both for public and private bodies.

 

The EU's Blue Economy has been consistently growing over the last decades, and its future is promising. However, investments in innovation are needed to create new business opportunities and manage our ocean and sea resources in a sustainable manner. Investment in projects such as EMPORIA4KT will bolster this growth while helping to protect the ocean and its resources.

 

The kick-off meeting was held on Monday April 29th, 2019 in Lisbon (Portugal), gathering 14 partners from 5 countries. More information will be made available online via social media, and via a project website which is currently in development; www.emporia4kt.com.

 

For press enquiries, please contact Communications and Press Officer Rebecca Doyle at Rebecca@aquatt.ie, or contact coordinator António Grilo at emporia4kt@campus.fct.unl.pt for more information on the project.

 

Statement Ends

 

ENQUIRIES

 

Frontier IP Group Plc

T: 020 7332 2338

Neil Crabb, Chief Executive

Andrew Johnson, Communications & Investor Relations

Company website: www.frontierip.co.uk

 

M: 07464 546 025

Allenby Capital Limited (Nominated Adviser and Broker)

T: 0203 328 5656

Nick Athanas / Nicholas Chambers (Corporate Finance)

Amrit Nahal (Equity Sales)

 

ABOUt EMPORIA4KT

The EMPORIA4KT project will run from 2019 - 2022 with an overall budget of approximately €2.2 million. EMPORIA4KT is funded by the European Union's Interreg Atlantic Area European Regional Development Fund.

EMPORIA4KT is coordinated by Universidade Nova de Lisboa -Faculdade de Ciências e Tecnologia (Nova School of Science and Technology). AquaTT is the project communication and dissemination partner. The project involves partners from Portugal, Ireland, France, Spain and the United Kingdom. Working collaboratively across these countries will enable the share of resources and knowledge by five countries with significant interest in the sustainable exploitation of marine resources.

ABout frontier IP

Frontier IP unites science and commerce by identifying strong intellectual property and accelerating its development through a range of commercialisation services. A critical part of the Group's work is involving relevant industry partners at an early stage of development to ensure technology meets real world demands and needs.

The Group looks to build and grow a portfolio of equity stakes and licence income by taking an active involvement in spin-out companies, including support for fund raising and collaboration with relevant industry partners at an early stage of development.

About RNS Reach announcements

This is an RNS Reach announcement. RNS Reach is an investor communication service aimed at assisting listed and unlisted (including AIM quoted) companies to distribute media only / non-regulatory news releases into the public domain. Information required to be notified under the AIM Rules for Companies, Market Abuse Regulation or other regulation would be disseminated as an RNS regulatory announcement and not on RNS Reach.

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRABSGDSLBDBGCC
Date   Source Headline
2nd May 20247:00 amRNSFrontier IP announces stake in DiaGen
17th Apr 20241:59 pmRNSHolding(s) in Company
12th Apr 20247:00 amRNSAppointment of Chief Financial Officer
2nd Apr 202412:44 pmRNSHolding(s) in Company
14th Mar 20247:00 amRNSUnaudited Half Year Results
4th Mar 20241:40 pmRNSHolding(s) in Company
29th Feb 20243:12 pmRNSSale of shares in Exscientia
30th Jan 202411:45 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSOctopus invest in Alusid as part of equity funding
29th Dec 202312:00 pmRNSTotal Voting Rights
19th Dec 20234:46 pmRNSHolding(s) in Company
15th Dec 20236:12 pmRNSReplacement - Result of AGM and Directorate Change
15th Dec 20232:07 pmRNSResult of AGM and Directorate Change
13th Dec 20237:00 amRNSPortfolio news - The Vaccine Group
11th Dec 20237:00 amRNSHolding(s) in Company
30th Nov 20235:00 pmRNSTotal Voting Rights
30th Nov 20237:00 amRNSExercise of Options & Director/PDMR Shareholdings
28th Nov 20237:00 amRNSBoard Change
21st Nov 20237:00 amRNSPosting of Annual Report and Notice of AGM
9th Nov 20235:27 pmRNSHolding(s) in Company
3rd Nov 20237:05 amRNSGrant of options
1st Nov 20235:48 pmRNSExercise of Options & PDMR Shareholdings & TVR
31st Oct 20237:01 amRNSBoard changes
31st Oct 20237:00 amRNSFinal results for the year ended 30 June 2023
23rd Oct 20237:00 amRNSNew portfolio company Deakin Bio-Hybrid Materials
12th Oct 20232:05 pmRNSHolding(s) in Company
21st Sep 20237:00 amRNSExscientia announces collaboration with Merck
14th Sep 20235:21 pmRNSHolding(s) in Company
14th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
11th Sep 20237:00 amRNSPortfolio news – Pulsiv appoints Chairman and CPO
8th Sep 20237:00 amRNSExercise of Options & Total Voting Rights
10th Aug 20238:45 amRNSPortfolio news – Fieldwork Robotics
24th Jul 20237:00 amRNSPortfolio news – CamGraPhIC loan facility
20th Jul 20235:18 pmRNSHolding(s) in Company
1st Jun 20237:00 amRNSSale of shares in Exscientia
26th May 20236:06 pmRNSHolding(s) in Company
9th May 20237:00 amRNSTopps Tiles launches first Alusid made tile range
21st Apr 20234:00 pmRNSDirectorate Change
20th Apr 20235:26 pmRNSHolding(s) in Company
27th Mar 20235:17 pmRNSHolding(s) in Company
17th Mar 20232:46 pmRNSGrant of options
15th Mar 20237:00 amRNSBoard changes
15th Mar 20237:00 amRNSUnaudited Half Year Results
30th Jan 20237:00 amRNSAlusid in collaboration with Imerys
9th Jan 20237:00 amRNSCelerum appoints David Gladding as CEO
9th Dec 20224:08 pmRNSResult of AGM
7th Dec 20221:25 pmEQSThe Vaccine Group completes two deadly disease vaccination projects
6th Dec 20227:00 amRNSFrontier IP to host Portfolio Demo Day
5th Dec 20227:00 amRNSThe Vaccine Group completes Lassa fever project
2nd Dec 20227:00 amRNSThe Vaccine Group completes vaccine project

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.